.

Deeper Knowledge, Faster

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Healthtrust
Covington
Colorcon
AstraZeneca
Chinese Patent Office
Fish and Richardson
Merck
Boehringer Ingelheim
US Department of Justice
QuintilesIMS

Generated: September 20, 2017

DrugPatentWatch Database Preview

Details for Patent: ► Subscribe

« Back to Dashboard

Which drugs does patent 6,066,339 protect, and when does it expire?


Patent ► Subscribe protects AVINZA and is included in one NDA. There have been two Paragraph IV challenges on Avinza.

This patent has twelve patent family members in twelve countries.

Summary for Patent: ► Subscribe

Title: Oral morphine multiparticulate formulation
Abstract:An oral morphine multiparticulate formulation for once-daily administration to a patient, comprising sustained release particles each having a core containing water soluble morphine and an osmotic agent, the core being coated with a rate-controlling polymer coat comprised of ammonio methacrylate copolymers in an amount sufficient to achieve therapeutically effective plasma levels of morphine over at least 24 hours in the patient.
Inventor(s): Stark; Paul (Althone, IE), Cunningham; Sean (Althone, IE), Moodley; Jagathesan (Althone, IE)
Assignee: Elan Corporation, plc (Dublin, IE)
Application Number:08/977,965
Patent Claim Types:
see list of patent claims
Formulation;

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
King Pharms Llc
AVINZA
morphine sulfate
CAPSULE, EXTENDED RELEASE;ORAL021260-001Mar 20, 2002DISCNNoNo► Subscribe► SubscribeY
King Pharms Llc
AVINZA
morphine sulfate
CAPSULE, EXTENDED RELEASE;ORAL021260-005Dec 18, 2008DISCNNoNo► Subscribe► SubscribeY
King Pharms Llc
AVINZA
morphine sulfate
CAPSULE, EXTENDED RELEASE;ORAL021260-002Mar 20, 2002DISCNNoNo► Subscribe► SubscribeY
King Pharms Llc
AVINZA
morphine sulfate
CAPSULE, EXTENDED RELEASE;ORAL021260-006Dec 18, 2008DISCNNoNo► Subscribe► SubscribeY
King Pharms Llc
AVINZA
morphine sulfate
CAPSULE, EXTENDED RELEASE;ORAL021260-003Mar 20, 2002DISCNNoNo► Subscribe► SubscribeY
King Pharms Llc
AVINZA
morphine sulfate
CAPSULE, EXTENDED RELEASE;ORAL021260-004Mar 20, 2002DISCNNoNo► Subscribe► SubscribeY
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Patent: ► Subscribe

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Japan4535613► Subscribe
Japan2001520187► Subscribe
Spain2199378► Subscribe
European Patent Office1023051► Subscribe
Denmark1023051► Subscribe
Germany69721845► Subscribe
Canada2558783► Subscribe
Portugal1023051► Subscribe
Canada2306333► Subscribe
Australia5408098► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Dow
US Department of Justice
Argus Health
Novartis
Julphar
Citi
US Army
Boehringer Ingelheim
Federal Trade Commission
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot